Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02389088Completed
Open-label trial of letrozole in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of California, San Diego. Primary endpoints: Estradiol Levels at Week 6, Inhibin B Levels at Week 6 and 2 more. Started Apr 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02389088.